Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

[Value of MRI in detection of extracapsular extension in prostate cancer: a prospective study comparing imaging and histology].

Albert T, Pasquali R, Giusiano S, Roland G, Rossi D, Bastide C.

Prog Urol. 2014 Feb;24(2):102-7. doi: 10.1016/j.purol.2013.07.015. Epub 2013 Aug 30. French.

PMID:
24485079
2.

[Preoperative endorectal MRI in prostate cancer: a monocentric retrospective cohort].

de Vendin C, Eydant Y, Ecochard R, Lorin S, Lacroix B, Lardon R, Mottet N.

Prog Urol. 2013 Dec;23(16):1412-8. doi: 10.1016/j.purol.2013.04.019. Epub 2013 Aug 27. French.

PMID:
24274946
3.

The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.

Somford DM, Hamoen EH, Fütterer JJ, van Basten JP, Hulsbergen-van de Kaa CA, Vreuls W, van Oort IM, Vergunst H, Kiemeney LA, Barentsz JO, Witjes JA.

J Urol. 2013 Nov;190(5):1728-34. doi: 10.1016/j.juro.2013.05.021. Epub 2013 May 13.

PMID:
23680307
4.

Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?

Latchamsetty KC, Borden LS Jr, Porter CR, Lacrampe M, Vaughan M, Lin E, Conti N, Wright JL, Corman JM.

Can J Urol. 2007 Feb;14(1):3429-34.

PMID:
17324322
5.

Does body-coil magnetic-resonance imaging have a role in the preoperative staging of patients with clinically localized prostate cancer?

Allen DJ, Hindley R, Clovis S, O'Donnell P, Cahill D, Rottenberg G, Popert R.

BJU Int. 2004 Sep;94(4):534-8.

6.

Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examination.

Xylinas E, Yates DR, Renard-Penna R, Seringe E, Bousquet JC, Comperat E, Bitker MO, Grenier P, Rouprêt M.

World J Urol. 2013 Aug;31(4):881-6. doi: 10.1007/s00345-011-0811-z. Epub 2011 Dec 23.

PMID:
22193518
7.

[Results of endorectal MRI in local staging of prostatic cancer. Correlation with specimens from prostatectomy. Apropos of 47 cases].

Chefchaouni MC, Flam T, Cornud F, Thiounn N, Belin X, Deslignères S, Zerbib M, Moreau JL, Debré B.

J Urol (Paris). 1996;102(2):51-5. Review. French.

PMID:
8796175
8.

Endorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: should we reconsider the indirects signs of extracapsular extension according to the D'Amico tumor risk criteria?

Cornud F, Rouanne M, Beuvon F, Eiss D, Flam T, Liberatore M, Zerbib M, Delongchamps NB.

Eur J Radiol. 2012 Apr;81(4):e591-7. doi: 10.1016/j.ejrad.2011.06.056. Epub 2011 Aug 25.

PMID:
21871750
9.

Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy.

Roethke MC, Lichy MP, Kniess M, Werner MK, Claussen CD, Stenzl A, Schlemmer HP, Schilling D.

World J Urol. 2013 Oct;31(5):1111-6. doi: 10.1007/s00345-012-0826-0. Epub 2012 Jan 17.

PMID:
22249342
10.

Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI.

Bloch BN, Genega EM, Costa DN, Pedrosa I, Smith MP, Kressel HY, Ngo L, Sanda MG, Dewolf WC, Rofsky NM.

Eur Radiol. 2012 Oct;22(10):2201-10. doi: 10.1007/s00330-012-2475-5. Epub 2012 Jun 3.

11.

Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.

Rosenkrantz AB, Chandarana H, Gilet A, Deng FM, Babb JS, Melamed J, Taneja SS.

J Magn Reson Imaging. 2013 Aug;38(2):312-9. doi: 10.1002/jmri.23972. Epub 2012 Dec 12.

PMID:
23238968
12.

Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.

Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.

Acta Radiol. 2008 Dec;49(10):1207-13. doi: 10.1080/02841850802508959.

PMID:
19031184
13.

Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.

Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC, Billebaud T, Delmas V, Meulemans A, Toublanc M, Boccon-Gibod L.

Urology. 1994 Sep;44(3):371-6.

PMID:
7521093
14.

Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results.

Bloch BN, Furman-Haran E, Helbich TH, Lenkinski RE, Degani H, Kratzik C, Susani M, Haitel A, Jaromi S, Ngo L, Rofsky NM.

Radiology. 2007 Oct;245(1):176-85. Epub 2007 Aug 23.

PMID:
17717328
15.

[Accuracy of endorectal Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer].

Baccos A, Schiavina R, Zukerman Z, Busato F, Gaudiano C, Salizzoni E, Fiorentino M, Golfieri R, Martorana G.

Urologia. 2012 Apr-Jun;79(2):116-22. doi: 10.5301/RU.2012.9207. Italian.

16.

Value of endorectal magnetic resonance imaging at 3T for the local staging of prostate cancer.

Otto J, Thörmer G, Seiwerts M, Fuchs J, Garnov N, Franz T, Horn LC, Do MH, Stolzenburg JU, Kahn T, Moche M, Busse H.

Rofo. 2014 Aug;186(8):795-802. doi: 10.1055/s-0033-1356186. Epub 2014 Feb 20.

17.

Ability of preoperative 3.0-Tesla magnetic resonance imaging to predict the absence of side-specific extracapsular extension of prostate cancer.

Hara T, Nakanishi H, Nakagawa T, Komiyama M, Kawahara T, Manabe T, Miyake M, Arai E, Kanai Y, Fujimoto H.

Int J Urol. 2013 Oct;20(10):993-9. doi: 10.1111/iju.12091. Epub 2013 Jan 29.

18.

[Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].

Wetter A, Ajdukovic AN, Fliessbach K, Lehnert T, Engl T, Jacobi V, Vogl TJ.

Rofo. 2006 Apr;178(4):385-90. German.

PMID:
16607587
19.

Assessment of the risk of positive surgical margins with pelvic phased-array magnetic resonance imaging in patients with clinically localized prostate cancer: a prospective study.

Soulié M, Aziza R, Escourrou G, Seguin P, Tollon C, Molinier L, Bachaud J, Joffre F, Plante P.

Urology. 2001 Aug;58(2):228-32.

PMID:
11489708
20.

A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.

D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Schnall M, Tomaszewski JE, Wein A.

J Urol. 1995 Jul;154(1):131-8.

PMID:
7539857

Supplemental Content

Support Center